Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine plus Glulisine vs Premixed Insulin in Type 2 Diabetes
NCT02987751Phase 4Completed
- Sponsor
- Dr. A. Ramachandran's Diabetes Hospitals
- Start
- Dec 2016
- Primary completion
- Sep 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Dr. A. Ramachandran's Diabetes Hospitals. Started Dec 2016; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02987751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02987751.